These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23140181)

  • 1. Duocarmycin SA Reduces Proliferation and Increases Apoptosis in Acute Myeloid Leukemia Cells In Vitro.
    Chen WA; Williams TG; So L; Drew N; Fang J; Ochoa P; Nguyen N; Jawhar Y; Otiji J; Duerksen-Hughes PJ; Reeves ME; Casiano CA; Jin H; Dovat S; Yang J; Boyle KE; Francis-Boyle OL
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting RIOK2 ATPase activity leads to decreased protein synthesis and cell death in acute myeloid leukemia.
    Messling JE; Agger K; Andersen KL; Kromer K; Kuepper HM; Lund AH; Helin K
    Blood; 2022 Jan; 139(2):245-255. PubMed ID: 34359076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yinzhihuang injection induces apoptosis and suppresses tumor growth in acute myeloid leukemia cells.
    Huang Z; Shen Y; Fan X; Guo Q; Ma W
    PLoS One; 2023; 18(10):e0289697. PubMed ID: 37816017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibitory Effect of Small Molecule Compound TIC10 on Leukemia].
    Chen T; Li L; Chen Z; Hou Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(5):1284-1289. PubMed ID: 37846673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The F1Fo-ATPase inhibitor protein IF1 in pathophysiology.
    Gatto C; Grandi M; Solaini G; Baracca A; Giorgio V
    Front Physiol; 2022; 13():917203. PubMed ID: 35991181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defueling the cancer: ATP synthase as an emerging target in cancer therapy.
    Wang T; Ma F; Qian HL
    Mol Ther Oncolytics; 2021 Dec; 23():82-95. PubMed ID: 34703878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Multifaceted ATPase Inhibitory Factor 1 (IF1) in Energy Metabolism Reprogramming and Mitochondrial Dysfunction: A New Player in Age-Associated Disorders?
    Gore E; Duparc T; Genoux A; Perret B; Najib S; Martinez LO
    Antioxid Redox Signal; 2022 Aug; 37(4-6):370-393. PubMed ID: 34605675
    [No Abstract]   [Full Text] [Related]  

  • 8. The function of Cav-1 in MDA-MB-231 breast cancer cell migration and invasion induced by ectopic ATP5B.
    Dong X; Li Y; Li W; Kang W; Tang R; Wu W; Xing Z; Zhou L
    Med Oncol; 2021 May; 38(6):73. PubMed ID: 34009483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural products and other inhibitors of F
    Patel BA; D'Amico TL; Blagg BSJ
    Eur J Med Chem; 2020 Dec; 207():112779. PubMed ID: 32942072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic state.
    Rath EM; Cheng YY; Pinese M; Sarun KH; Hudson AL; Weir C; Wang YD; Håkansson AP; Howell VM; Liu GJ; Reid G; Knott RB; Duff AP; Church WB
    PLoS One; 2018; 13(8):e0203003. PubMed ID: 30157247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Antibodies for Myeloid Neoplasms-Current Developments and Future Directions.
    Schürch CM
    Front Oncol; 2018; 8():152. PubMed ID: 29868474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A humanized chimeric antibody Hai178 targeted to the β subunit of F1F0 ATP synthase.
    Chen C; Liang H; Liao X; Pan J; Chen J; Zhao S; Xu Y; Wu Y; Ni J
    Tumour Biol; 2016 Oct; ():. PubMed ID: 27704358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal Phosphoproteome Dynamics Induced by an ATP Synthase Inhibitor Citreoviridin.
    Hu CW; Hsu CL; Wang YC; Ishihama Y; Ku WC; Huang HC; Juan HF
    Mol Cell Proteomics; 2015 Dec; 14(12):3284-98. PubMed ID: 26503892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors for the treatment of cancer in companion animals.
    Walsh M; Fais S; Spugnini EP; Harguindey S; Abu Izneid T; Scacco L; Williams P; Allegrucci C; Rauch C; Omran Z
    J Exp Clin Cancer Res; 2015 Sep; 34(1):93. PubMed ID: 26337905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between IL-4 -588C>T polymorphism and NHL susceptibility.
    Sun Z; Pei J; Cui F; Jing Y; Hu C
    Tumour Biol; 2014 May; 35(5):4897-900. PubMed ID: 24464250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the ecto-beta subunit of F1F0-ATPase inhibits proliferation and induces apoptosis in acute myeloid leukemia cell lines.
    Wen-Li Z; Jian W; Yan-Fang T; Xing F; Yan-Hong L; Xue-Ming Z; Min Z; Jian N; Jian P
    J Exp Clin Cancer Res; 2012 Nov; 31(1):92. PubMed ID: 23140181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual functions of a monoclonal antibody against cell surface F1F0 ATP synthase on both HUVEC and tumor cells.
    Zhang X; Gao F; Yu LL; Peng Y; Liu HH; Liu JY; Yin M; Ni J
    Acta Pharmacol Sin; 2008 Aug; 29(8):942-50. PubMed ID: 18664327
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.